BridgeMD
New treatment option for Aging Well
Official title Effect of Aromatherapy for Facial Aesthetics in Alleviating Signs of Aging: Pilot Study
ClinicalTrials.gov ID: NCT06527066
What this study is testing
What is Geranium (Pelargonium graveolens) essential oil (EO) diluted to 1% in All.me Beauty® Gel Sérum Biocompatível?
Geranium (Pelargonium graveolens) essential oil (EO) diluted to 1% in All.me Beauty® Gel Sérum Biocompatível is an investigational medicine, given as a twice-daily pill taken by mouth, being studied as a potential treatment for aging well.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Introduction: aesthetics is one of the specialties for professional nurses and presents a dialogue with Aromatherapy, a practice that uses essential oils (EO) from aromatic plants, being one of the most used integrative therapies for beauty care, youth and well-being. EOs are volatile compounds extracted from the most diverse parts of plants and some, such as geranium (Pelargonium graveolens), have antioxidant action, acting in the regeneration and maintenance of skin tissue, becoming a potential ally in the prevention and/or treatment of wrinkles, as well as general skin aging.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 55, women only
You may be able to join if
- cisgender women;
- 45 to 55 years old;
- classification of II and III on the Glogau Scale;
- agree to participate in the research considering the conditions and stages of the study protocol;
- do not present adverse reactions to the topical use of the essential oil and its carrier base.
You likely can't join if
- pregnant women;
- breastfeeding women;
- people diagnosed with neurological, serious dermatological diseases and others serious illnesses;
- people with facial injuries;
- severe allergies or occurrence of serious adverse events due to the use of cosmetics and/or cosmeceuticals in the past;
- participants who present an allergic reaction during the allergenicity test and/or during the study;
See the full eligibility criteria
- cisgender women;
- 45 to 55 years old;
- classification of II and III on the Glogau Scale;
- agree to participate in the research considering the conditions and stages of the study protocol;
- do not present adverse reactions to the topical use of the essential oil and its carrier base.
- pregnant women;
- breastfeeding women;
- people diagnosed with neurological, serious dermatological diseases and others serious illnesses;
- people with facial injuries;
- severe allergies or occurrence of serious adverse events due to the use of cosmetics and/or cosmeceuticals in the past;
- participants who present an allergic reaction during the allergenicity test and/or during the study;
- those who underwent aesthetic facial procedures with fillers (except lip fillers) and botulinum toxin up to 6 months before the start of the protocol, PDO threads up to 3 months before, and chemical, mechanical and...
- use of cosmeceuticals seven to ten days before participating in the study, as well as during it, with only the use of photoprotector being permitted and recommended;
- people who have undergone facial aesthetic surgery, except rhinoplasty.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.